Skip to content
Screener

Pulse Biosciences, Inc. PLSE Other Income (Expense)

Discontinued — last reported Q2 '26

Other Income (Expense) at other companies

Abbott logo
AbbottABT
$134M-2.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$331M-209%
AtriCure logo
AtriCureATRC
-$100K-112%
Medtronic logo
MedtronicMDT
$137M
Merit Medical Systems logo
Merit Medical SystemsMMSI
$9.39M+405%
AngioDynamics logo
AngioDynamicsANGO
$4.88M-12.3%

Segments

By segment

See full
Single Reportable-$615K+44.4%

Other financials

Income statement

See full
Revenue$434.0K
Gross profit$161.0K
Operating income-$25.3M-24.6%
Net income-$24.7M-28.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$101.6M-4.4%
Total debt$6.8M-17.9%
Total equity$99.5M-4.8%
Total assets$115.6M-3.9%

Cash flow

See full
Operating cash flow-$18.7M-46.1%
CapEx$90.0K-12.6%
Free cash flow-$18.8M-45.6%

Valuation

See full
Market cap$2.65B+202%
Enterprise value$2.55B+224%
P/S2,233.4×

Profitability

See full
Gross margin-0.1%
Operating margin-7,007.8%
Net margin-6,755.8%
FCF margin-5,180.4%

Returns & leverage

See full
Return on equity-78.5%-15.3pp
Debt / equity0.1×0.0×
Current ratio9.6×-2.4×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-026288
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other income (expense):
Interest income6001,1291,1932,384
Other income (expense)15(22)(9)(28)
Total other income6151,1071,1842,356
Net loss(24,657)(19,168)(43,238)(35,963)
Comprehensive loss$(24,657)$(19,168)$(43,238)$(35,963)
Net loss per share, basic and diluted$(0.36)$(0.28)$(0.63)$(0.54)
Weighted average common shares outstanding, basic and diluted69,200,02067,275,60868,600,62367,201,198

Document

FAQ

What is Pulse Biosciences, Inc.'s other income (expense)?
Pulse Biosciences, Inc. (PLSE) reported other income (expense) of $615K in Q2 2026.
How has Pulse Biosciences, Inc.'s other income (expense) changed year-over-year?
Pulse Biosciences, Inc.'s other income (expense) decreased by 44.4% year-over-year, from $1.11M to $615K.
What is the long-term trend for Pulse Biosciences, Inc.'s other income (expense)?
Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s other income (expense) has grown at a 59.3% compound annual growth rate (CAGR), from -$646K to $4.16M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Pulse Biosciences, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude